Highly accomplished Biopharma Chief Medical Officer with 20+ years of global leadership specializing in strategic pipeline acceleration to meet projected product positioning, applied clinical pharmacology, in infectious disease /Rare disease drug development. Expert in bridging translational science with commercial reality from phase 1-4, having advanced multiple assets through successful IND, NDA, and sNDA approvals across […]
I am a biotechnology scientific leader and advisor with more than 30 years of experience in academic research, oncology, and therapeutic development. I help emerging companies evaluate target biology and therapeutic candidates, identify evidence gaps, and design experiments that guide development decisions. My expertise includes preclinical pharmacology, translational strategy, GPCR biology, targeted protein degradation, biomarkers, […]
I am a PhD-trained molecular diagnostics and pathology laboratory leader with 20+ years of experience in hospital laboratory leadership, precision oncology, clinical genomics, translational research, and U.S. biotechnology. I currently direct molecular oncology, NGS, IHC, quality, workflow, technology evaluation, and laboratory operations. My consulting strengths include NGS implementation and validation, oncology biomarker and IHC implementation, […]
Radiopharmaceutical and biomarker development leader with a 30 year record of advancing first in human imaging agents, shaping regulatory strategy, and driving clinical translation for oncology, neurology, and inflammation therapeutics. Architect of large, complex radiopharmaceutical portfolios across academia, big pharma, and venture backed biotech. Tenured professor, prolific scientific author, and physician sponsor of more than […]
I am a translational R&D scientist and Scientific Director with over 15 years of experience developing therapies for rare neuromuscular and neurodegenerative disease. My expertise spans RNA-based therapeutics and gene therapy, from early discovery through clinical translation, with hands-on experience across academia and industry. My technical background includes antisense oligonucleotide (ASO) design and mechanism, exon-skipping […]
• Program & Facility Leadership: Oversight of NIH-Vaccine Research center’s bioanalytical mass spectrometry facility supporting GMP vaccine manufacturing – strategic planning, capital budgeting, resource allocation, purchase coordination. • Analytical Strategy & CMC Integration: End-to-end analytical leadership for monoclonal antibodies, subunit vaccines, and mRNA therapeutics. • Cross-Functional Collaboration: Partnering with cell line development, purification, formulation, automation, […]
Professor of Respiratory Immunology with expertise in translational immunology, inflammatory lung disease, pulmonary fibrosis and asthma. I advise on therapeutic target identification and validation, biomarker strategy, drug discovery and preclinical development. My research focuses on macrophage biology, immunometabolism and human experimental medicine. I have experience advising biotechnology and pharmaceutical companies on scientific strategy, therapeutic development […]
Physician-Founder and CEO of Predicate AI Labs, focused on developing next-generation health intelligence technologies at the intersection of AI, physiological computing, digital health, medical devices, and edge computing. My expertise includes health technology strategy, product development, clinical innovation, commercialization, strategic partnerships, global health, and early-stage venture development. I advise organizations on emerging technologies, market opportunities, […]
Anthony Shimkin is an AI-first medtech and life sciences commercial leader with a passion for driving change across the healthcare and diagnostics industries. Currently based in San Diego, he leads commercial strategy at Diagnostic Ventures, bringing a multidisciplinary background spanning MS, MBA, and MA credentials. His expertise encompasses commercialization, go-to-market strategy, digital marketing, and customer […]
I am a medical oncologist and drug developer dedicated to translating innovative science into breakthrough therapies for patients with cancer. As Executive Chair of Head & Neck Research at Sarah Cannon Research Institute, I am recognized as a key opinion leader in head & neck oncology, shaping the design and execution of early clinical development […]